TEMODAR J Code: J8700

Drug & Product Overview

HCPCS Descriptor Temozolomide, oral, 5 mg

HCPCS Added Date January 1, 2001

Manufacturer Multiple Manufacturers

Route of Administration Oral

Generic Status Multi-Source; Generic

Dosage Type Single-Dose

Dosage Form Capsule | Not Available

About TEMODAR

Temodar is a medication aligned to the HCPCS J Code: J8700 for billing, pricing, and reimbursement purposes in the United States. This Oncology medication is administered via the oral route and manufactured by multiple companies.

According to CMS Drug Use Information: This medication is used to treat certain types of brain cancer. Temozolomide belongs to a class of drugs known as alkylating agents. It works by slowing or stopping the growth of cancer cells.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. Showing 5 of 60 NDCs — log in for the full crosswalk.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
16729-0048-53	Temozolomide	Accord Healthcare Inc.	5	5 MG
16729-0050-53	Temozolomide	Accord Healthcare Inc.	100	100 MG
47335-0890-72	Temozolomide	Sun Pharmaceutical Industries, Inc.	15	5 MG
50268-0761-12	Temozolomide	AvPAK	80	20 MG
65162-0801-14	Temozolomide	Amneal Pharmaceuticals LLC	14	5 MG
•••••-••••-•• Log in to view	TEMODAR
	TEMODAR
	TEMODAR

Login to view 55 more NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

TEMODAR Pricing & Reimbursement

J8700 Private Payer Reimbursement

$1.01 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q4 2026

TEMODAR Claims Performance

Claims from Jan 2026 – Aug 2026

Claim Denial Rate 62.5%

Avg. Days to File 83.7days

Avg. Days to Pay 102.6days

Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.

Explore J8700 claims analytics on FocalPoint →

TEMODAR Medically Unlikely Edits (MUE)

The most billing units of J8700 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 5 mg. The limit is different in the office and the hospital. Use the one for your setting.

Practitioner Office

0 units / day

Not payable in this setting

Hospital Outpatient

120 units / day

= 600 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

Not on the CMS JW / JZ list

CMS does not include Temodar (J8700) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J8700. Wastage billing guide →

TEMODAR Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Anaplastic Astrocytoma Newly Diagnosed Glioblastoma Refractory Anaplastic Astrocytoma

Drug Class

Alkylating Activity [MoA]Alkylating Drug [EPC]

Frequently Asked Questions

Is there an available Temodar billing and coding guide?

We have not yet identified a manufacturer source of Temodar billing and coding information.

Are there any available Temodar patient assistance programs?

Our team did not identify a source for Temodar patient assistance information. Please reach out to our team if you feel that this is a mistake.

Where can I find Temodar prescribing information?

TEMODAR prescribing information can be found at the link below: Visit Here →

Where can I find Temodar side effect information?

Information regarding TEMODAR's side effects can be found at MedlinePlus Visit Here →

Does billing TEMODAR require JZ/JW wastage modifiers?

CMS does not include TEMODAR (J8700) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J8700. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.